v3.25.1
Schedule of Deferred Tax Assets and Related Valuation Allowances (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Reserves and other $ 731,000 $ 796,000
Net operating loss carry-forwards 27,869,000 26,494,000
Capitalized research and development 3,894,000 3,946,000
Research and development tax credit 2,205,000 1,326,000
Share-based compensation 1,430,000 1,108,000
Warrant liability (2,860,000)
Derivative liability (688,000)
Valuation Allowance (36,129,000) (30,122,000)
Net deferred tax asset